Thermo Fisher Scientific and DuPont Nutrition & Health have agreed to renew their Distribution Agreement for Western Europe, allowing Thermo Fisher to maintain exclusive supply of the DuPont BAX System Q7 platform in the region for at least the next 3 years. Thermo Fisher will also continue to supply the BAX System Q7 on an exclusive basis in Australia and New Zealand and on a nonexclusive basis in Canada under separate agreements.

The original agreement, started 14 years ago, enabled Thermo Fisher to supply the BAX System Q7 in Western Europe and other territories, becoming one of the first companies to offer customers a more rapid way to detect pathogens in foods, enabling them to take faster actions including releasing product to market sooner. Thermo Fisher will continue to offer the DuPont BAX System Q7 platform for foodborne pathogen detection alongside their Thermo Scientific Real-time PCR Solutions, providing customers with the broadest choice of molecular food tests from any single manufacturer.

“We are delighted to continue our current arrangement with DuPont,” says Andy Thomson, president, microbiology, Thermo Fisher Scientific. “Real-time PCR methods provide quick and accurate detection of microbial pathogens in a broad range of foods and associated samples, and at Thermo Fisher we are dedicated to continuous development of validated methods to help our customers protect their brands whilst releasing product to market as soon as possible.”

George McVay, Diagnostics global business and integrated operations leader, DuPont Nutrition & Health, says, “Thermo Fisher’s office-based and in-field specialists have a long history of supporting the BAX System Q7, and the technical expertise and experience they can provide our customers in these regions is unparalleled. We look forward to continuing our current arrangement to serve and support our food manufacturing and contract laboratory customers.”